about
Financial cost of lymphedema borne by women with breast cancer.Competing considerations in regional nodal treatment for early breast cancer.Prognostic value of the lymph node ratio for lymph-node-positive breast cancer- is it just a denominator problem?Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis.Can an Immediate 2-stage Breast Reconstruction Be Performed After Previous Conservative Surgery and Radiotherapy?Lipidomic Profiling of Adipose Tissue Reveals an Inflammatory Signature in Cancer-Related and Primary Lymphedema.Liposuction for Advanced Lymphedema: A Multidisciplinary Approach for Complete Reduction of Arm and Leg SwellingWorse and worse off: the impact of lymphedema on work and career after breast cancerBreast Augmentation after Conservation Surgery and Radiation Therapy."Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.Qualitatively understanding patients' and health professionals' experiences of the BRECONDA breast reconstruction decision aid.Breast Cancer-Related Lymphedema: Differentiating Fat from Fluid Using Magnetic Resonance Imaging Segmentation.Sexual concerns of women diagnosed with breast cancer-related lymphedema.Toward the breast screening balance sheet: cumulative risk of false positives for annual versus biennial mammograms commencing at age 40 or 50.Psychological distress and streamlined BreastScreen follow-up assessment versus standard assessment.Reducing Decisional Conflict and Enhancing Satisfaction with Information among Women Considering Breast Reconstruction following Mastectomy: Results from the BRECONDA Randomized Controlled Trial.Treatment of the axilla in early breast cancer: past, present and future.Locally advanced breast cancer: defining an optimum treatment regimen.Projecting mammographic screens.Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.Estimating the benefits of adjuvant systemic therapy for women with early breast cancer.Tumour location is not an independent prognostic factor for survival following a diagnosis of breast cancer.Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.The impact of changes in hormone therapy on breast cancer incidence in the US population.Internal mammary sentinel nodes: ignore, irradiate or operate?HRT and breast cancer: impact on population risk and incidence.Two-Stage Prosthetic Breast Reconstruction after Mastectomy with or without Prior Postmastectomy Radiotherapy.The value of follow-up of patients with early breast cancer treated with conservative surgery and radiation therapy.A decision tool for predicting sentinel node accuracy from breast tumor size and grade.Tumour size as a predictor of axillary node metastases in patients with breast cancer.Radiation therapy and early breast cancer: current controversies."You're naked, you're vulnerable": Sexual well-being and body image of women with lower limb lymphedema.Regret associated with the decision for breast reconstruction: the association of negative body image, distress and surgery characteristics with decision regret.Is information from axillary dissection relevant to patients with clinically node-negative breast cancer?Psychosocial factors associated with adherence for self-management behaviors in women with breast cancer-related lymphedema.Immediate two-stage prosthetic breast reconstruction failure: radiation is not the only culprit.Cerebral hemisphere astrocytoma: treatment results.Primary breast cancer of the vulva: A case report and literature reviewThe management of early breast carcinoma before and after the introduction of clinical practice guidelines
P50
Q33834070-131AE793-069E-4465-B519-595178D01C02Q34539312-738089C6-BE58-4290-A813-817CCB67F6EDQ35196745-52CF2BB5-DCAC-419B-A100-0AB1E97F3C8FQ35757885-D615DE77-09B0-4A12-9C08-9CCA26B43BDAQ35837432-5738A712-1E1B-4DF7-994D-42A1E029C5C4Q35924602-5A74F09B-1797-459F-94F9-0ACC7CD40CDFQ36018490-4B10078A-A7B2-47F8-8C3E-5963DB93D4DAQ36391783-E0364E86-F31F-4FFE-A87F-2AD1E46FF25CQ36910404-BBAA8B51-D4B5-4E08-BF1F-0019E1DDDCC1Q37158979-DB7271AB-697C-460D-8CC8-0F8473924D03Q37481901-235A4B1F-3559-40AC-9C1E-CD944B2E2CFCQ38558660-BC2AE359-C633-42B4-8C66-FABDE4837D1DQ38873633-A4122799-3E28-4F4A-BE7A-A59B59EEAAB9Q39024623-E135DF7E-C1E4-4E83-AA04-3E2B89EFC335Q39083717-AF6166C3-2B12-4125-80F1-EED01D0DD140Q39322613-CCEDDCB5-A0B4-4A25-A691-072A2BA10886Q39347344-AD29867D-863B-4CC3-9211-9ED1D71683FEQ40651601-C4C04E00-1B2E-41C6-9016-DA926B0459ACQ40730740-14DAF580-138A-4204-852D-A2E1C74D8ADDQ40733879-660D289B-0DB1-494D-90FB-EDB4FEBE5C4DQ40859481-E6EBDF4A-57B8-40A2-9123-8D74A127E583Q43782367-A3E3E000-CDDD-463C-BCC6-A4365DFFB7B1Q44015332-1170065B-E11C-40B6-9259-43ED96ACD072Q44132814-D02E8B2B-AFFD-4AD4-A851-03FBB7FD08ADQ45008883-BEFB947C-957B-4EB7-9246-CAB7329596FAQ46176240-BACD523D-6345-4011-B89B-F9908AB3F7D1Q46640589-FAFBE274-7005-4A40-9FCB-908D96F52200Q47138902-D56F75CE-F4EE-461B-81C0-8AD0A633B3D9Q47203612-4EA7AC94-4652-414B-9279-C89D2B50D43DQ47262876-252D392B-FDD5-4C20-871A-05551E144AF9Q47316750-3A89B593-0D3D-4E01-B33B-06E8E69E9426Q49542749-CBDA9018-7092-4DE5-ACC3-C57C468DCF01Q50195206-656B56E5-E5F5-46D5-8020-9EADBA689D62Q50874154-6BEDDFFB-3E87-47D4-8D32-4D942DDB96E4Q52008051-77BCB595-9018-47E8-95CC-9438CA9049A1Q53512439-DCD15210-22E8-416B-94CD-C9446CD3DC00Q54214497-B50D42FB-F662-4E6E-94AA-5EC0DB166613Q55487187-ABF139ED-F498-4942-872F-5B106E687AC7Q57107747-8908D45C-2D49-4D76-BCE6-8EC857E3813DQ57265850-95FDA60D-ACA6-421C-933E-5FEB9D71D225
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John Boyages
@ast
John Boyages
@en
John Boyages
@es
John Boyages
@nl
type
label
John Boyages
@ast
John Boyages
@en
John Boyages
@es
John Boyages
@nl
prefLabel
John Boyages
@ast
John Boyages
@en
John Boyages
@es
John Boyages
@nl
P106
P1153
56187784800
P31
P496
0000-0003-3208-3966